A Study to Evaluate Progesterone and Inflammatory Mediators in High-risk Pregnancies

Official Title: Progesterone and Inflammatory Mediators in High-risk Pregnancies (Cortisol)

Purpose:

This observational study is being conducted to measure the levels of cortisol and other hormones in women who are receiving progesterone therapy to prevent a preterm birth.

Eligibility criteria:

- one fetus, no genetic disorders or fetal malformations detected
- Not currently on progesterone therapy
- History of Preterm Birth (PTB), start progesterone therapy 16-20 weeks
- Control group, no history of PTB
- Gestational age 16-20 weeks at enrollment

Contact Information


Anna Bartholomew, RN
614-685-3229
Anna.Bartholomew@osumc.edu

Back